Xponance, Inc. Kymera Therapeutics, Inc. Transaction History
Xponance, Inc.
- $12.3 Billion
- Q3 2025
A detailed history of Xponance, Inc. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 3,983 shares of KYMR stock, worth $253,438. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,983Holding current value
$253,438% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
229Shares Held
72.9MCall Options Held
155KPut Options Held
54.2K-
Baker Bros. Advisors LP New York, NY6.65MShares$423 Million3.07% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.35MShares$404 Million4.91% of portfolio
-
Bvf Inc San Francisco, CA5.5MShares$350 Million9.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.42MShares$345 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA5.2MShares$331 Million0.05% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $3.48B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...